BioSpace News Archive

Drug Development

Genentech’s Ipatasertib Has Mixed Results in Prostate Cancer Trial

The company indicated the initial data was promising, but the data for overall survival benefit and additional secondary endpoints were not yet mature and the trial will continue.

June 19, 2020
·
2 min read
·
Mark Terry
Drug Development

Clinical Trials Are Starting Back Up, but Some Future Approvals May be Delayed

According to a BioPharma Dive report, since March, more than 100 biopharma companies announced their clinical trials were disrupted in some way because of the pandemic.

June 19, 2020
·
3 min read
·
Mark Terry
Policy

FDA Action Alert: Karyopharm, Zogenix, Chiasma, Heron, Intercept and Merck

Wrapping up June and ahead of the July 4 holiday, the U.S. Food and Drug Administration (FDA) has a busy two-week period coming up for drug approvals. Here’s a look.

June 19, 2020
·
3 min read
·
Mark Terry
FDA

FDA Approves Bone-Softening Disorder Treatment Crysvita

Crysvita is a drug developed by Ultragenyx Pharmaceutical and Tokyo-based Kyowa Kirin Co. Ltd., a specialty pharmaceutical company.

June 19, 2020
·
2 min read
·
Alex Keown
Drug Development

Clinical Catch-Up: June 15-19

It was a busy week for clinical trial announcements. Here’s a look.

June 19, 2020
·
12 min read
·
Mark Terry
FDA

Epizyme’s Tazverik Picks Up Its Second FDA Approval of 2020

The FDA approved a supplemental New Drug Application for Tazverik (tazemetostat) for the treatment of two distinct follicular lymphoma (FL) indications.

June 19, 2020
·
2 min read
·
Alex Keown
Business

UV-C Light Kills SARS-CoV-2, Triggering Novel Lighting Options for Public Spaces

UV-C light has been used as a disinfectant against viruses and bacteria for more than 40 years. Now, researchers at Boston University and Signify (formerly Phillips) have confirmed that it also effectively eradicates the SARS-CoV-2 virus.

June 19, 2020
·
3 min read
·
Gail Dutton
Drug Development

Finch’s Live Microbiome Drug Shows Promise in C. Diff Treatment

Finch Therapeutics reported positive topline results from PRISM3, its Phase II trial of CP101, an oral microbiome drug for the prevention of recurrent C. difficile infection.

June 19, 2020
·
3 min read
·
Mark Terry
Mobile Hospitals Market: Trends, Opportunities & Regional Outlook

Even in crisis situations, such as war and earthquake trucks, trailers, trains, aircraft and ships that provide medical attention to people in need, mobile hospital can be moved into any part of the world.

June 19, 2020
·
3 min read
Medical Radiation Shielding Market - Increasing use of Nuclear Medicine and Radiation Therapies Drive Market Growth

The International Atomic Energy Agency describes the process of radiation protection or radiation shielding as the protection of humans from the negative impact they may receive when exposed to harmful values of ionizing radiation.

June 19, 2020
·
5 min read